I now have comprehensive information from the textbooks and web sources to write a thorough answer. Let me compile this.
Stages of Hair Loss & Treatment
Understanding the Hair Loss Cycle
Hair loss (alopecia) occurs when the normal hair cycle - anagen (growth), catagen (transition), telogen (rest) - is disrupted. In androgenetic alopecia (AGA), the most common type, DHT (dihydrotestosterone) progressively miniaturizes terminal pigmented hairs into fine, hypopigmented vellus hairs. Stem cells in the follicle bulge are preserved in bald scalp, but progenitor cells are markedly reduced, which is why follicles stop producing hair shafts.
Stages of Hair Loss
Males - Hamilton-Norwood Scale (7 Stages)
Developed by Hamilton (1951) and revised by Norwood (1975), this is the global standard for grading male pattern baldness.
| Stage | Description | Key Feature |
|---|
| Stage 1 | No clinically significant hair loss | Hairline at original position - baseline |
| Stage 2 | Slight bilateral recession at temples | "M"-shaped mature hairline; symmetrical |
| Stage 3 | Deep recession at temples, pronounced "M" or "U" shape | First stage considered clinically significant hair loss |
| Stage 3 Vertex | Significant loss at the crown (vertex) with relatively spared frontal line | Crown bald patch appears |
| Stage 4 | More pronounced temple recession + thinning at crown, separated by a band of hair | Two distinct balding zones |
| Stage 5 | The two bald areas enlarge; the separating band thins | Band of hair still present but narrow |
| Stage 6 | Temple and crown zones merge completely | "Monk's baldness" - continuous bald area across top |
| Stage 7 | Most advanced stage - only a narrow horseshoe band of hair remains at sides and back | Entire top of head bald |
Type A variants (Stages 2A-5A): Hair recedes uniformly front-to-back, without a distinct vertex bald spot forming separately.
Females - Ludwig Scale (3 Grades)
Female pattern hair loss is diffuse thinning over the crown, unlike the distinct zones in men. The Ludwig scale grades severity:
| Grade | Description |
|---|
| Grade I | Thinning noticeable on the crown, part line widens; frontal hairline preserved |
| Grade II | Significant diffuse thinning over the crown with wider part |
| Grade III | Nearly complete baldness over crown; frontal hairline still maintained |
The Sinclair scale is also used, rating females on a 1-5 scale with Grade 1 = normal parting width and Grade 5 = diffuse thinning similar to male pattern.
Pathogenesis
- DHT-driven miniaturization: 5α-reductase converts testosterone to DHT, which binds androgen receptors in hair follicles and shortens anagen (growth) phase progressively
- Genetics: Polygenic inheritance; androgen receptor gene (AR) on the X chromosome (Xq11-12) is the major determinant in men. The AR-CAG repeat polymorphism inversely correlates with androgen sensitivity
- Prostaglandin D2 (PGD2): Elevated in bald scalp; inhibits hair growth via its receptors (a therapeutic target under investigation)
- Wnt/β-catenin signaling: Recent 2025 research identified suppression of this pathway as an additional mechanism in follicular miniaturization
Medical Treatment
1. Minoxidil (Topical & Oral)
- Topical: 5% solution/foam in men; 2% in women (FDA-approved). Applied once or twice daily to the scalp
- Oral low-dose minoxidil: 0.25-2.5 mg/day - effective and generally well-tolerated (Goldman-Cecil Medicine)
- Mechanism: Vasodilator that prolongs anagen phase and increases follicle size
- Key point: Stopping minoxidil causes an acute telogen efflux 3-4 months later (hair shed accelerates). Regular use is mandatory to maintain results.
2. Finasteride (Oral)
- Dose: 1 mg/day orally (FDA-approved for men only)
- Mechanism: Inhibits 5α-reductase, reducing conversion of testosterone to DHT
- Effect: Slows progression and promotes regrowth - improvement mostly seen as thickening of existing hairs
- Caution: Post-finasteride syndrome - persistent sexual dysfunction and depression reported in some men after stopping
- Stopping finasteride leads to gradual return of hair loss, reaching pretreatment status within ~1 year
3. Finasteride Topical Spray
- As effective as oral finasteride but with less systemic impact on DHT levels - preferred where systemic side effects are a concern
4. Dutasteride (Oral)
- Dose: 0.5 mg/day (approved in some countries, e.g., Japan, South Korea)
- Inhibits both type 1 and type 2 5α-reductase (vs. finasteride which inhibits only type 2)
- More effective than finasteride with a comparable safety profile
5. Spironolactone / Anti-androgens (Women)
- Spironolactone (100-200 mg/day) and cyproterone acetate used in women to block androgen receptors
- Not appropriate for men due to feminizing side effects
General Treatment Notes
- All medical treatments should be continued for at least 6 months before assessing efficacy
- A 2025 network meta-analysis confirmed that the combination of finasteride + minoxidil is the most effective medical regimen for AGA in men
- Early intervention (Stages 1-2) yields the best outcomes - preserving existing hair is easier than restoring lost hair
Non-Pharmacological Treatments
Platelet-Rich Plasma (PRP)
- Injections of concentrated autologous growth factors into the scalp
- Stimulates follicle activity and prolongs anagen
- A typical protocol: 3 monthly injections + 1 booster at 3 months
- Evidence is mixed - one RCT found PRP vs. saline gave similar results; more standardization of protocols is needed
- Used adjunctively with minoxidil/finasteride for better outcomes
Low-Level Laser Therapy (LLLT) / Photobiomodulation
- FDA-cleared devices (laser combs, helmets, caps)
- Stimulates mitochondrial activity in hair follicles and extends anagen phase
- A 2025 evidence-based consensus in JAAD supports its use as an adjunct therapy
- Best suited for Norwood Stages 2-4
Surgical Treatment: Hair Transplantation
Hair transplantation is based on donor dominance - terminal hairs from the unaffected posterior/occipital scalp maintain their growth pattern even after transplantation to balding areas.
Techniques
| Technique | How it Works |
|---|
| FUT (Follicular Unit Transplantation / Strip) | A strip of scalp is excised from the donor area; individual follicular units are dissected and transplanted |
| FUE (Follicular Unit Extraction) | Individual follicular units (1-4 hairs each) are extracted one by one using a punch device and transplanted |
- Modern transplants use individual follicular units (1-4 hairs per graft), producing a natural appearance - a revolution from the older "plug" method
- Post-transplant, patients are encouraged to continue topical/oral minoxidil and finasteride to slow ongoing miniaturization and maximize the perceived density
Candidate Criteria
- Suitable for men with Norwood Stages 3-7 with adequate donor hair density
- Female transplantation is more complex - diffuse thinning in the parietal/occipital region means the donor area may also be affected
- Young patients (Stage 3) should consider 12-18 months of medical therapy first to assess the final pattern before committing to surgery
Treatment by Stage (Summary)
| Stage | Recommended Approach |
|---|
| 1-2 | Preventive: lifestyle optimization, early minoxidil or finasteride |
| 3-3V | Minoxidil + finasteride; consider PRP or LLLT as adjuncts |
| 4-5 | Combination medical therapy; hair transplant if progressing |
| 6-7 | Hair transplant (FUE/FUT) is primary option; medical therapy to protect remaining hair |
Alopecia Areata (Patchy Hair Loss) - Brief Note
This is a distinct autoimmune, non-scarring form affecting up to 2% of the population. Triggered by a CD8+ T-cell attack on hair follicles via the
JAK/STAT pathway. Treatment now includes
JAK inhibitors - ritlecitinib and baricitinib are approved (a
2025 systematic review confirmed ritlecitinib vs. baricitinib efficacy). Severe forms: alopecia totalis (entire scalp) or alopecia universalis (all body hair).
Sources: Dermatology 2-Volume Set 5e (Elsevier), Goldman-Cecil Medicine (International Edition), Andrews' Diseases of the Skin; supplemented by PubMed 2024-2025 systematic reviews and the Hamilton-Norwood classification.